Evidence map›Paper›PMID 33546361›Full record

ReviewCells2021

Intestinal Stem Cell Development in the Neonatal Gut: Pathways Regulating Development and Relevance to Necrotizing Enterocolitis.

Aparna Venkatraman, Wei Yu, Christopher Nitkin, Venkatesh Sampath

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Aparna VenkatramanDivision of Neonatology, Department of Pediatrics, Children's Mercy Hospital, Kansas City, MO 64108, USA.
Wei YuDivision of Neonatology, Department of Pediatrics, Children's Mercy Hospital, Kansas City, MO 64108, USA.
Christopher NitkinDivision of Neonatology, Department of Pediatrics, Children's Mercy Hospital, Kansas City, MO 64108, USA.ORCID 0000-0001-5718-4523
Venkatesh SampathDivision of Neonatology, Department of Pediatrics, Children's Mercy Hospital, Kansas City, MO 64108, USA.
Children's Mercy Hospital · US

Funding

Single Immunoglobulin Interleukin-1 Related Receptor and necrotizing enterocolitis in premature infantsR01DK117296 · NIDDK · CHILDREN'S MERCY HOSP (KANSAS CITY, MO) · PI SAMPATH, VENKATESH, UMAR, SHAHID · 2018 to 2022
$2.6M
NIDDK NIH HHS R01 DK117296NIH HHS 5R01 DK117296-03
6 · The paper itself

Abstract

The intestine is extremely dynamic and the epithelial cells that line the intestine get replaced every 3-5 days by highly proliferative intestinal stem cells (ISCs). The instructions for ISCs to self-renew or to differentiate come as cues from their surrounding microenvironment or their niche. A small number of evolutionarily conserved signaling pathways act as a critical regulator of the stem cells in the adult intestine, and these pathways are well characterized. However, the mechanisms, nutritional, and environmental signals that help establish the stem cell niche in the neonatal intestine are less studied. Deciphering the key signaling pathways that regulate the development and maintenance of the stem cells is particularly important to understanding how the intestine regenerates from necrotizing enterocolitis, a devastating disease in newborn infants characterized by inflammation, tissues necrosis, and stem cell injury. In this review, we piece together current knowledge on morphogenetic and immune pathways that regulate intestinal stem cell in neonates and highlight how the cross talk among these pathways affect tissue regeneration. We further discuss how these key pathways are perturbed in NEC and review the scientific knowledge relating to options for stem cell therapy in NEC gleaned from pre-clinical experimental models of NEC.

Indexed as

AnimalsCell DifferentiationDisease Models, AnimalEnterocolitis, NecrotizingHumansMesenchymal Stem Cellsexosomesimmune signalingintestinal stem cellsmesenchymal stem cell therapymorphogentic pathwaysnecrotizing enterocolits

Identifiers

PMID33546361
PMCPMC7913590
OpenAlexW3127391946

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.